ArticleFrontiers in immunology2026

Identification of LILRB4 as a regulator of M2c macrophages and a potential immunotherapeutic target in ovarian cancer.

Huijuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.